Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1993 Jul;68(1):32–36. doi: 10.1038/bjc.1993.282

Impaired cytokine production in whole blood cell cultures of patients with gynaecological carcinomas in different clinical stages.

U Elsässer-Beile 1, S von Kleist 1, W Sauther 1, H Gallati 1, J S Mönting 1
PMCID: PMC1968320  PMID: 8318418

Abstract

The production of the cytokines IFN-gamma, IL-1-alpha, IL-2 and TNF-alpha was investigated in mitogen-stimulated, whole blood cell culture from 239 untreated patients with primary gynaecological carcinomas (breast, cervix, ovary, endometrium), and 191 healthy female controls. The cytokines were measured in the 4-day post-induction supernatants by a sensitive enzymoimmunological assay. In the blood cell cultures of all four groups of cancer patients, significantly lower values of IFN-gamma (P < or = 0.001), IL-2 (P < or = 0.01) and IL-1 alpha (P < or = 0.01) were found as compared to the controls, although lymphocyte and monocyte counts were almost identical. Grouping the tumour patients into different clinical stages we could show in the four groups of carcinomas a gradual depression of the cytokine production according to growing tumour burden.

Full text

PDF
32

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bjercke S., Onsrud M., Gaudernack G. Suppressive effect of monocytes in vitro in patients with carcinoma of the uterine cervix. Acta Obstet Gynecol Scand. 1986;65(6):619–624. doi: 10.3109/00016348609158399. [DOI] [PubMed] [Google Scholar]
  2. Bolton P. M., Mander A. M., Davidson J. M., James S. L., Newcombe R. G., Hughes L. E. Cellular immunity in cancer: comparison of delayed hypersensitivity skin tests in three common cancers. Br Med J. 1975 Jul 5;3(5974):18–20. doi: 10.1136/bmj.3.5974.18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Dean J. H., Connor R., Herberman R. B., Silva J., McCoy J. L., Oldham R. K. The relative proliferation index as a more sensitive parameter for evaluating lymphoproliferative responses of cancer patients to mitogens and alloantigens. Int J Cancer. 1977 Sep 15;20(3):359–370. doi: 10.1002/ijc.2910200307. [DOI] [PubMed] [Google Scholar]
  4. Elsässer-Beile U., von Kleist S., Fischer R., Mönting J. S. Impaired cytokine production in whole blood cell cultures from patients with colorectal carcinomas as compared to benign colorectal tumors and controls. J Clin Lab Anal. 1992;6(5):311–314. doi: 10.1002/jcla.1860060510. [DOI] [PubMed] [Google Scholar]
  5. Elsässer-Beile U., von Kleist S., Gallati H. Evaluation of a test system for measuring cytokine production in human whole blood cell cultures. J Immunol Methods. 1991 Jun 3;139(2):191–195. doi: 10.1016/0022-1759(91)90188-l. [DOI] [PubMed] [Google Scholar]
  6. Elsässer-Beile U., von Kleist S., Gallati H., Pfleiderer A. Evaluation of cytokine levels in whole cell cultures of patients with gynaecological tumors as diagnostic parameters. Anticancer Res. 1991 May-Jun;11(3):1093–1095. [PubMed] [Google Scholar]
  7. Elsässer-Beile U., von Kleist S., Stähle W., Schurhammer-Fuhrmann C., Mönting J. S., Gallati H. Cytokine levels in whole blood cell cultures as parameters of the cellular immunologic activity in patients with malignant melanoma and basal cell carcinoma. Cancer. 1993 Jan 1;71(1):231–236. doi: 10.1002/1097-0142(19930101)71:1<231::aid-cncr2820710136>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  8. Evans J. T., Goldrosen M. H., Minowada J., Howell J., Mittelman A., Chu T. M., Holyoke E. D. Cell-mediated immune status of colon cancer patients: evaluation by dermal antigen testing, measurment of lymphocyte stimulation and counts of peripheral blood rosette-forming cells. Cancer. 1977 Nov;40(5 Suppl):2716–2725. doi: 10.1002/1097-0142(197711)40:5+<2716::aid-cncr2820400946>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  9. Fritze D., Dystant P. Detection of impaired mitogen responses in autologous whole blood of cancer patients using an optimized method of lymphocyte stimulation. Immunol Lett. 1984;8(5):243–247. doi: 10.1016/0165-2478(84)90003-8. [DOI] [PubMed] [Google Scholar]
  10. Gallati H., Pracht I., Schmidt J., Häring P., Garotta G. A simple, rapid and large capacity ELISA for biologically active native and recombinant human IFN gamma. J Biol Regul Homeost Agents. 1987 Jul-Sep;1(3):109–118. [PubMed] [Google Scholar]
  11. Hakim A. A. Peripheral blood lymphocytes from patients with cancer lack interleukin-2 receptors. Cancer. 1988 Feb 15;61(4):689–701. doi: 10.1002/1097-0142(19880215)61:4<689::aid-cncr2820610412>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  12. Rey A., Klein B., Zagury D., Thierry C., Serrou B. Diminished interleukin-2 activity production in cancer patients bearing solid tumors and its relationship with natural killer cells. Immunol Lett. 1983 Mar;6(3):175–178. doi: 10.1016/0165-2478(83)90101-3. [DOI] [PubMed] [Google Scholar]
  13. Santos L. B., Yamada F. T., Scheinberg M. A. Monocyte and lymphocyte interaction in patients with advanced cancer. Evidence for deficient IL-1 production. Cancer. 1985 Oct 1;56(7):1553–1558. doi: 10.1002/1097-0142(19851001)56:7<1553::aid-cncr2820560715>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  14. Stein J. A., Adler A., Efraim S. B., Maor M. Immunocompetence, immunosuppression, and human breast cancer. I. An analysis of their relationship by known parameters of cell-mediated immunity in well-defined clinical stages of disease. Cancer. 1976 Sep;38(3):1171–1187. doi: 10.1002/1097-0142(197609)38:3<1171::aid-cncr2820380319>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  15. Wanebo H. J., Pace R., Hargett S., Katz D., Sando J. Production of and response to interleukin-2 in peripheral blood lymphocytes of cancer patients. Cancer. 1986 Feb 1;57(3):656–662. doi: 10.1002/1097-0142(19860201)57:3<656::aid-cncr2820570343>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  16. Wanebo H. J., Thaler H. T., Hansen J. A., Rosen P. P., Robbins G. F., Urban J. A., Oettgen H. F., Good R. A. Immunologic reactivity in patients with primary operable breast cancer. Cancer. 1978 Jan;41(1):84–94. doi: 10.1002/1097-0142(197801)41:1<84::aid-cncr2820410113>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  17. Yron I., Schickler M., Fisch B., Pinkas H., Ovadia J., Witz I. P. The immune system during the pre-cancer and the early cancer period. IL-2 production by PBL from post-menopausal women with and without endometrial carcinoma. Int J Cancer. 1986 Sep 15;38(3):331–338. doi: 10.1002/ijc.2910380306. [DOI] [PubMed] [Google Scholar]
  18. Zembala M., Mytar B., Popiela T., Asherson G. L. Depressed in vitro peripheral blood lymphocyte response to mitogens in cancer patients: the role of suppressor cells. Int J Cancer. 1977 May 15;19(5):605–613. doi: 10.1002/ijc.2910190503. [DOI] [PubMed] [Google Scholar]
  19. Zielinski C. C., Mueller C., Tyl E., Tichatschek E., Kubista E., Spona J. Impaired production of tumor necrosis factor in breast cancer. Cancer. 1990 Nov 1;66(9):1944–1948. doi: 10.1002/1097-0142(19901101)66:9<1944::aid-cncr2820660916>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES